Purpose:The aim was to investigate the effect of Nd:YAG capsulotomy on refraction, intraocular pressure and anterior chamber depth changes and complications of Nd:YAG laser treatment for posterior capsular opacification in pseudophakic eyes. Methods: Our study includes 26 eyes (23 patients) with posterior capsular opacification after uncomplicated phacoemulsification surgery and intraocular lens implantation. Complete ocular examinations were performed for all patients. The visual acuity, intraocular pressure and anterior chamber depth measurements were obtained in all examinations. Nd:YAG capsulotomy was measured in all patients. Eyes received one drop of aproclonidine 0.5 % before and immediately after YAG laser capsulotomy. Data were analysed statistically. Results: Mean patient age was 53.73 Ϯ 13.53 years. Before Nd:YAG capsulotomy mean anterior chamber depth was 4.03 Ϯ 0.58 mm and in the first day after capsulotomy the mean value was 4.02 Ϯ 0.46 mm. Mean spherical equivalent refraction before laser treatment was -0.52 D and on the first day after laser treatment was -0.49 D. An improvement in visual acuity was achieved in all cases. Before Nd:YAG capsulotomy mean visual acuity was 0.38 Ϯ 0.13 and on the first day after capsulotomy, the mean value was 0.93 Ϯ 0.11, the difference of which was statistically significant. There were no statistically significant differences between the anterior chamber depth and intraocular pressure measurements before laser capsulotomy and on the first day, first month and third month after laser. Conclusion: Nd:YAG laser capsulotomy is an effective and safe method of treatment of posterior capsular opacification.

Rose K lenses are a viable alternative in the visual rehabilitation of patients with keratoconus.

Phacoemulsification power should be kept at minimum in order to induce minimal trauma and to achieve early rehabilitation.

PHACO surgery combined with IVTA injection improves BCVA and provides a decrease in CMT in diabetic patients with CSME. Additional macular grid laser photocoagulation after surgery helps to preserve this improvement in BCVA and decrease in CMT.

There is a temporary therapeutic effect of posterior subtenon's triamcinolone injection without laser photocoagulation. GLP improves VA and reduces the risk of recurrent macular edema after posterior STTA injection.

Purpose:To evaluate the intraocular pressure (IOP) reducing effect of a fixed combination of 0.005% latanoprost and 0.5% timolol in patients with an IOP of 30 mmHg or higher.Design:Prospective, randomized clinical trial.Participants: Twenty-eight patients.Methods:Patients had received no prior medical glaucoma treatment. Routine ophthalmic examinations and visual field tests were performed before and after treatment for each patient.Results:Mean IOP was 32.28 ± 0.92 mmHg before treatment. Mean IOP levels were 18.75 ± 0.68 for the first day, 17.96 ± 0.90 for the first week and 17.64 ± 0.66 for the first month after treatment.Conclusion:A fixed combination of latanoprost 0.005% and timolol 0.5% is effective in significantly reducing IOP in glaucoma patients with an IOP greater than 30 mmHg.

Purpose: To evaluate the use of posterior sub‐tenon triamcinolone acetonide (PSTA) injection on clinical, angiographic, and optical coherence tomographic (OCT) parameters in diabetic macular edema (DME). Methods: In a prospective clinical sudy, 36 eyes of 33 patients with (DME). and a decrease in visual acuity were included. Posterior sub‐tenon injection of 40 mg of TA was given under topic anesthesia. All patients were evaluated at baseline and at 1 day, 1, 2, 4, 6, and 8 weeks, and 3, 6, and 9 months after injection. In some of the patients injections were repeated after 3 months. Complete ophthalmologic examination, fluorescein angiography, and OCT were performed before intervention and after 3 months. The main outcome measures were visual acuity (VA), central macular thickness(CMT), intraocular pressure (IOP), cataract progression, and frequency of complications. Results: The mean baseline CMT for all eyes was 543μ. The mean CMT was 301μ at 1 month, Twenty‐one of the 36 treated eyes showed visual improvement in at least two lines of visual acuity. Nine eyes showed no improvement in vision. Most of them already had poor visual acuity (0.2 or less) before the injections. Complications of the treatment included cataract in three eyes, glaucoma in one. Injection of repository corticosteroids into the posterior sub‐Tenon space is of value in the treatment of CME secondary to uveitis. However, we have to beware of the complications of treatment. Conclusions: PST injection of TA is effective in reversing CME and improving visual acuity in DME

No abstract